“Great vision without great people is irrelevant."
Jim Collins
Co-Founder and CEO
Chief Technology Officer
Chief Medical Officer
VP of Quality and Operations
Head of Clinical Operations
Director of Finance and Business Development
Director of Program Management
Director of Research
Director of Operations
Director of Engineering & Transfer
Preclinical Research Manager
Product Engineer III
Research Chemist II
Sr. Design Assurance Engineer
Associate Manager, Clinical Operations
Research Scientist II
Operations Manager
Scientist I
We are always looking for hard-working, passionate individuals who are excited to bring new contraceptive options to the world. If you enjoy working in small teams and solving difficult problems, you'd be a great fit for Contraline.
We are always looking for hard-working, passionate individuals who are excited to bring new contraceptive options to the world. If you enjoy working in small teams and solving difficult problems, you'd be a great fit for Contraline.
Marty is an executive with over 30 years of experience leading medical device companies with innovative technologies through approval and commercialization. Previously, he served as the CEO of American Medical Systems, a publicly-traded urology and gynecology device company with sales of over $500 million (acquired by Boston Scientific for $1.6 billion), as the president and CEO of Galil Medical (acquired for $110M by BTG plc), and currently serves as the president and CEO of Monteris Medical. He holds a Bachelor of Science in Accounting from Marquette University.
Gurdane Bhutani is Founder and Managing Partner at MBX Capital, an early stage healthcare venture fund. He previously was COO of FundRx, a healthcare and life sciences investment marketplace, and prior to FundRx, at Bain & Company and Morgan Stanley. Gurdane is a Kauffman fellow and bears dual-degree in computer science and public policy from Duke University, and a MPH from Yale University.
Dr. Michael King is a professor of practice in the Department of Chemical Engineering at the University of Virginia. Mike had a 32-year industrial experience at Merck and Co, Inc. including responsibilities in both the research and manufacturing areas related to the commercialization of new pharmaceuticals and vaccines. He retired as senior VP and advisor to the chairman, president and CEO of Merck. He is currently engaged with the Bill and Melinda Gates Foundation in helping de-risk commercialization of a new vaccine technology and previously, was on the Board of Directors of Medivation (acq. by Pfizer).
Kevin co-founded Contraline and has been CEO since its inception. At Contraline, Kevin provides vision, leads fundraising, and business development. He is an inventor on 50+ patents relating to novel contraceptive drugs and devices, biomaterials, drug delivery, and surgical devices. He has a degree in Nanomedicine Engineering from the University of Virginia with minors in Chemistry and Biomedical Engineering. He was listed on the Forbes 30 under 30 in Healthcare.
Dr. Craig Niederberger is a Professor and Head of the Department of Urology at the University of Illinois at Chicago. He also holds a joint appointment as Professor in the Department of Bioengineering in the College of Engineering at UIC. He is co-editor in chief of Fertility and Sterility and served as an editor for the Journal of Urology. He is a co-founder of the surgical device company NexHand.
Dr. Aaron Spitz has been practicing urology for over 21 years. He has specialized expertise in male reproductive medicine and male sexual health, and is a nationally recognized expert on vasectomy, vasectomy reversal, sperm retrieval surgery, and Peyronie's disease. He received the Distinguished Service Award from the AUA in 2020 and is currently Chairman of the AUA's Telehealth Task Force.
Dr. Jay Sandlow is a fellowship trained specialist in male infertility. He is experienced in microsurgery, as well as minimally invasive treatments for male contraception. He has co-authored the national guidelines for vasectomy and male infertility. His goal is to provide state-of-the-art, cutting edge diagnosis and treatments to his patients and couples, often emphazing patient education and participation.
Dr. Meng Deng is an Associate Professor of Agricultural and Biological Engineering, Materials Engineering, and Biomedical Engineering at Purdue University. His research interests include biomaterials, drug delivery, nanotechnology, and regenerative engineering. Dr. Deng serves as associate editor for Frontiers in Bioengineering and Biotechnology and on the editorial board of Regenerative Engineering and Translational Medicine. He is also founder of Adipo Therapeutics.
1948-2016
Contraline is deeply rooted in Dr. John Herr's essence. Dr. Herr was a visionary, a scientist, and an entrepreneur at the forefront of reproductive biology. Contraline continues in the legacy of our co-founder by working relentlessly to develop new reproductive health technologies. Learn more about John here.